Age-related macular degeneration (AMD), classified into dry and wet types, poses a significant threat to the vision of the ...

How you prepare your morning cup of joe could be linked to an eye disease that affects nearly 20 million Americans.

Older people with diabetes who do not keep blood sugar levels low are three times more likely to develop eye disease compared ...

In this video from Clinical Trials at the Summit, Carl D. Regillo, MD, FACS, discusses the use of tyrosine kinase inhibitors for wet age-related macular degeneration and diabetic retinopathy with ...

Whether you’re a latte lover, a mocha monster or an espresso elitist — people have strong preferences when it comes to coffee ...

You probably already have a hunch that green beans are super healthy for you. This article covers the nutrition basics, plus ...

Newer techniques using nanoparticles are less invasive, but some need bright visible light, which can harm any remaining ...

Alcon has inked a deal to acquire LumiThera and its light-based therapy for dry age-related macular degeneration, which obtained a groundbreaking FDA clearance late last year. | LumiThera's approach ...

In this paper we present our latest robotic setup, which has been modified for sub-retinal interventions. The setup consists of: 1) sub-retinal micro cannula with automatic pump; 2) Micromanipulator; ...

Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults. Current treatments mainly address advanced AMD, while early or intermediate stages rely only on micronutrient ...

PST-611-CT1 is a first-in-human single ascending dose study that aims to establish, in six to a maximum of 12 dry AMD/GA patients, the safety profile of the drug and validate the maximal tolerated ...

Blurry, distorted vision is a common symptom of wet AMD (age-related macular degeneration). Your eyes may also have difficulty adjusting to changes in lighting. Wet AMD is a chronic eye condition ...